Science Explorer Back to mapMap
Discussion
Company · Taoyuan City · Taiwan

Simpson Biotech Company (Taiwan)

simpsonbiotech.com/index.asp?lang=2ROR OpenAlex
Research works
15
▲ 173% vs 2018-21
Citations
155
10.0 per fractional work
Top-10% rate
14.1%
all institutions 10.0%
Open access
52%
world 40%
International
39%
world 18%
Simpson Biotech Company (Taiwan)

Not ranked overall: Simpson Biotech Company (Taiwan) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Simpson Biotech Company (Taiwan) work in?

In all years, 55% of research at Simpson Biotech Company (Taiwan) is in Life Sciences, 29% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (37%), Medicine (25%), Engineering (9%). It does 2.2× the world's share of Life Sciences.

Life Sciences: 9 fractional works · 55.2% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 37.3% of its workMolecular Biology: 3 fractional works · 21.2% of its workCell Biology: 1 fractional works · 7.0% of its workBiotechnology: 1 fractional works · 5.7% of its workCancer Research: 0 fractional works · 2.5% of its workBiochemistry: 0 fractional works · 0.5% of its workEndocrinology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 8.8% of its workPlant Science: 1 fractional works · 5.0% of its workFood Science: 1 fractional works · 3.7% of its workImmunology and Microbiology: 1 fractional works · 4.3% of its workImmunology: 0 fractional works · 2.7% of its workMicrobiology: 0 fractional works · 1.6% of its workNeuroscience: 1 fractional works · 3.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 2.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workSensory Systems: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.2% of its workPharmaceutical Science: 0 fractional works · 1.2% of its workHealth Sciences: 4 fractional works · 28.8% of its workMedicine: 4 fractional works · 25.2% of its workPharmacology: 1 fractional works · 5.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.5% of its workOncology: 0 fractional works · 2.1% of its workUrology: 0 fractional works · 2.1% of its workPathology and Forensic Medicine: 0 fractional works · 1.9% of its workComplementary and alternative medicine: 0 fractional works · 1.5% of its workObstetrics and Gynecology: 0 fractional works · 1.4% of its workGenetics: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 1.1% of its workEpidemiology: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.7% of its workReproductive Medicine: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 1 fractional works · 3.6% of its workNutrition and Dietetics: 1 fractional works · 3.6% of its workPhysical Sciences: 2 fractional works · 16.0% of its workEngineering: 1 fractional works · 9.4% of its workAerospace Engineering: 0 fractional works · 2.8% of its workBiomedical Engineering: 0 fractional works · 2.1% of its workComputational Mechanics: 0 fractional works · 1.2% of its workElectrical and Electronic Engineering: 0 fractional works · 1.1% of its workCivil and Structural Engineering: 0 fractional works · 0.6% of its workControl and Systems Engineering: 0 fractional works · 0.5% of its workMechanics of Materials: 0 fractional works · 0.5% of its workBuilding and Construction: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 2.8% of its workMaterials Chemistry: 0 fractional works · 2.3% of its workSurfaces, Coatings and Films: 0 fractional works · 0.5% of its workChemistry: 0 fractional works · 2.2% of its workOrganic Chemistry: 0 fractional works · 2.2% of its workEnvironmental Science: 0 fractional works · 0.9% of its workNature and Landscape Conservation: 0 fractional works · 0.5% of its workEcology: 0 fractional works · 0.4% of its workChemical Engineering: 0 fractional works · 0.7% of its workFluid Flow and Transfer Processes: 0 fractional works · 0.7% of its workALL ITS WORKSimpson BiotechCompany (Taiwan)16fractional works, all years
Life Sciences55%Physical Sciences16%Health Sciences29%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology637.3%
    2. Agricultural and Biological Sciences18.8%
    3. Immunology and Microbiology14.3%
    4. Neuroscience13.6%
    5. Pharmacology, Toxicology and Pharmaceutics01.2%
    1. Medicine425.2%
    2. Nursing13.6%
    1. Engineering19.4%
    2. Materials Science02.8%
    3. Chemistry02.2%
    4. Environmental Science00.9%
    5. Chemical Engineering00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.38× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.66× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.21× its world share, 0 worksImmunology and Micro…Neuroscience: 1.00× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.80× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.62× its world share, 0 worksChemistryEngineering: 0.40× its world share, 0 worksEngineeringEnvironmental Science: 0.16× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.46× its world share, 0 worksMaterials ScienceMedicine: 2.03× its world share, 3 worksMedicineNursing: 4.95× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.8×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.80×0 works
  2. Biochemistry, Genetics and Molecular Biology5.66×2 works
  3. Nursing4.95×0 works
  4. Immunology and Microbiology3.21×0 works
  5. Agricultural and Biological Sciences2.38×1 works
  6. Medicine2.03×3 works
  7. Neuroscience1.00×0 works
  8. Chemistry0.62×0 works
  9. Materials Science0.46×0 works
  10. Engineering0.40×0 works
  11. Environmental Science0.16×0 works

What are the most cited papers from Simpson Biotech Company (Taiwan)?

The most cited paper from Simpson Biotech Company (Taiwan) is "In vivo stimulatory effect of Cordyceps sinensis mycelium and its fractions on reproductive functions in male mouse" (Yuan‐Li Huang, Sew-Fen Leu, Bi-Ching Liu et al., 2004), with 48 citations. Next come "Improved secretory production of glucoamylase in Pichia pastoris by combination of genetic manipulations" (46) and "In vivo and in vitro stimulatory effects of Cordyceps sinensis on testosterone production in mouse Leydig cells" (44).

Most cited papers
#PaperReleasedCitations
1 In vivo stimulatory effect of Cordyceps sinensis mycelium and its fractions on reproductive functions in male mouse Yuan‐Li Huang, Sew-Fen Leu, Bi-Ching Liu et al. · Life Sciences 3 Jun 2004 48
2 Improved secretory production of glucoamylase in Pichia pastoris by combination of genetic manipulations Shi-Hwei Liu, Wei-I Chou, Chia-Chin Sheu et al. · Biochemical and Biophysical Research Communications 12 Dec 2004 46
3 In vivo and in vitro stimulatory effects of Cordyceps sinensis on testosterone production in mouse Leydig cells Chih-Chao Hsu, Yuan‐Li Huang, Shaw‐Jenq Tsai et al. · Life Sciences 22 Jul 2003 44
4 Effects of Cordyceps sinensis on testosterone production in normal mouse Leydig cells Bu‐Miin Huang, Chih-Chao Hsu, Shaw‐Jenq Tsai et al. · Life Sciences Oct 2001 42
5 Role of the linker region in the expression of Rhizopus oryzae glucoamylase Shu‐Chuan Lin, Wei-Ting Liu, Shi-Hwei Liu et al. · BMC Biochemistry Open access 25 Jun 2007 26
All 33 most cited papers, with filters and sorting

Which research topics does Simpson Biotech Company (Taiwan) publish most on?

By volume in 2022-now: Extracellular vesicles in disease, RNA Interference and Gene Delivery, MicroRNA in disease regulation and Phytochemistry and biological activity of medicinal plants.

Extracellular vesicles i…0Extracellular vesicles in disease: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksMicroRNA in disease regu…0MicroRNA in disease regulation: 0 fractional worksPhytochemistry and biolo…0Phytochemistry and biological activity of medicinal plants: 0 fractional worksHair Growth and Disorders: 0 fractional worksReproductive System and Pregnancy: 0 fractional worksPregnancy and preeclamps…0Pregnancy and preeclampsia studies: 0 fractional worksNatural Compound Pharmac…0Natural Compound Pharmacology Studies: 0 fractional works3D Printing in Biomedica…03D Printing in Biomedical Research: 0 fractional worksPolysaccharides Composit…0Polysaccharides Composition and Applications: 0 fractional works
Molecular BiologyCancer ResearchPlant ScienceUrology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Extracellular vesicles in disease Molecular Biology 0 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 0 works
  3. 3 MicroRNA in disease regulation Cancer Research 0 works
  4. 4 Phytochemistry and biological activity of medicinal plants Plant Science 0 works
  5. 5 Hair Growth and Disorders Urology 0 works
  6. 6 Reproductive System and Pregnancy Immunology 0 works
  7. 7 Pregnancy and preeclampsia studies Obstetrics and Gynecology 0 works
  8. 8 Natural Compound Pharmacology Studies Plant Science 0 works
  9. 9 3D Printing in Biomedical Research Biomedical Engineering 0 works
  10. 10 Polysaccharides Composition and Applications Food Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.8%not open48.2%

World: 40% of research is openly available.

with international co-authors39.4%domestic only60.6%

World: 18% is written across borders.

How has Simpson Biotech Company (Taiwan)'s research output changed?

Output in 2022-2025 was 173% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Simpson Biotech Company (Taiwan) as a percentage of every work published that year, 0.000013% in 2024.

still counting0.000020%0.000040%0.000060%Simpson Biotech Company (Taiwan)0.000057% in 202520102020

Fractional works of Simpson Biotech Company (Taiwan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Taoyuan City

All research institutions in Taoyuan City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Simpson Biotech Company (Taiwan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.